Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer

Abstract excerpt

With a lifetime risk estimated to be one in eight in industrialized countries, breast cancer is the most frequent type of cancer among women worldwide. Patients are often treated with anti-estrogens, but it is common that some tumors develop resistance to therapy. The causation and progression of cancer is controlled by epigenetic processes, so there is an ongoing interest in research into mechanisms, genes and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biological Research and Disease Studies
• Share to Cancer Research and Treatment
• Share to Histone Deacetylase Inhibitors Research